These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Airway inflammation in chronic obstructive pulmonary disease. Górska K; Maskey-Warzechowska M; Krenke R Curr Opin Pulm Med; 2010 Mar; 16(2):89-96. PubMed ID: 19904205 [TBL] [Abstract][Full Text] [Related]
4. Airway nitrergic pathways: is there therapeutic potential in asthma and COPD? Folkerts G; Nijkamp FP Curr Opin Pharmacol; 2004 Jun; 4(3):202-6. PubMed ID: 15140409 [TBL] [Abstract][Full Text] [Related]
5. Aspects on pathophysiological mechanisms in COPD. Larsson K J Intern Med; 2007 Sep; 262(3):311-40. PubMed ID: 17697154 [TBL] [Abstract][Full Text] [Related]
6. Effects of inhaled therapy on biomarkers of systemic inflammation in stable chronic obstructive pulmonary disease. Antoniu SA Biomarkers; 2010 Mar; 15(2):97-103. PubMed ID: 19929747 [TBL] [Abstract][Full Text] [Related]
7. [Pneumology. Inhaled corticosteroids in COPD: more and interesting data!]. Rochat T Rev Med Suisse; 2008 Jan; 4(140):155-7. PubMed ID: 18309880 [TBL] [Abstract][Full Text] [Related]
8. Angiogenesis: a potentially critical part of remodelling in chronic airway diseases? Walters EH; Reid D; Soltani A; Ward C Pharmacol Ther; 2008 Apr; 118(1):128-37. PubMed ID: 18358536 [TBL] [Abstract][Full Text] [Related]
9. [COPD: an inflammatory disease of the airways?]. Magnussen H Pneumologie; 2004 May; 58(5):320-4. PubMed ID: 15162257 [TBL] [Abstract][Full Text] [Related]
10. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis. Baker WL; Baker EL; Coleman CI Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942 [TBL] [Abstract][Full Text] [Related]
11. Inflammatory mechanisms and treatment of obstructive airway diseases with neutrophilic bronchitis. Simpson JL; Phipps S; Gibson PG Pharmacol Ther; 2009 Oct; 124(1):86-95. PubMed ID: 19555716 [TBL] [Abstract][Full Text] [Related]
12. [Role of inflammation in the etiopathogenesis of COPD]. del Puerto-Nevado L; Pérez-Rial S; Girón-Martínez A; Peces-Barba G Arch Bronconeumol; 2010 Dec; 46 Suppl 11():2-7. PubMed ID: 21316554 [TBL] [Abstract][Full Text] [Related]
14. [New concepts in the pathogenesis and pathophysiology of COPD]. Fira-Mladinescu O; Tudorache V; Mihăicută S; Muntean D Pneumologia; 2007; 56(1):24, 26-31. PubMed ID: 17491205 [TBL] [Abstract][Full Text] [Related]
15. [New pharmacological options in the therapy of COPD]. Watz H; Kanniess F; Magnussen H Pneumologie; 2007 Jun; 61(6):365-73. PubMed ID: 17492578 [TBL] [Abstract][Full Text] [Related]
16. Antiinflammatory therapies other than corticosteroids. Rennard SI Proc Am Thorac Soc; 2004; 1(3):282-7. PubMed ID: 16113447 [TBL] [Abstract][Full Text] [Related]
17. ATP and the pathogenesis of COPD. Mortaz E; Folkerts G; Nijkamp FP; Henricks PA Eur J Pharmacol; 2010 Jul; 638(1-3):1-4. PubMed ID: 20423711 [TBL] [Abstract][Full Text] [Related]
18. [Toll-like receptor in lung response to pathogens]. Rivas-Santiago B; Juárez E Rev Invest Clin; 2007; 59(6):481-8. PubMed ID: 18402340 [TBL] [Abstract][Full Text] [Related]
19. The non-neuronal cholinergic system in the airways: an unappreciated regulatory role in pulmonary inflammation? Gwilt CR; Donnelly LE; Rogers DF Pharmacol Ther; 2007 Aug; 115(2):208-22. PubMed ID: 17597218 [TBL] [Abstract][Full Text] [Related]